Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADDERALL XR in adolescents with ADHD
NCT00507065Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2003
- Primary completion
- Mar 2004
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of adderall xr in attention deficit hyperactivity disorder (ADHD), sponsored by Takeda. Started May 2003; status: completed.
02
Drugs
adderall xr
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00507065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507065.